OEL Fastrac catalog listing now available as a RSS feed

Affygility Solutions is pleased to announce that its OEL Fastrac catalog listing is now available as a RSS (Really Simple Syndication) feed. Listed below is an example of the feed displaying that latest six occupational exposure limit (OEL) with ADE monographs. Click on the compound name heading to go directly to the specific OEL/ADE monograph product page.

  • Ferric Citrate


    Ferric citrate is indicated for the treatment of high blood phosphate levels in chronic kidney disease. Ferric citrate lowers serum phosphate levels by binding to dietary phosphate in the GI tract as ferric iron and precipitating as ferric phosphate, which is excreted in the stool.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Ferric Citrate is available for purchase for $639 USD.

  • Glucagon


    Glucagon and its recombinant form are used to treat severe hypoglycemia (low blood sugar) and as a diagnostic aid to reduce intestinal movement during radiologic examinations. Glucagon is a protein produced by the pancreas that plays an important role in regulating the level of glucose in the blood.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Glucagon is available for purchase for $639 USD.

  • Nintedanib Esylate


    Nintedanib esylate is indicated for the treatment of idiopathic pulmonary fibrosis (IPF) (scarring of the lungs of unknown cause). Nintedanib esylate inhibits multiple receptor tyrosine kinase and receptor non-tyrosine kinases. Some of these are implicated in the process of IPF and nintedanib may work by blocking the enzymes involved in fibrosis.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Nintedanib Esylate is available for purchase for $639 USD.

  • Nicorandil


    Nicorandil is indicated for the prevention and long-term treatment of stable angina pectoris (chest pain cause by heart disease). Nicorandil is a potassium channel opener that causes vasodilation of small and large vessels of the heart.</p

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Nicorandil is available for purchase for $639 USD.

  • Hydroxychloroquine


    Hydroxychloroquine is indicated for the treatment of malaria, lupus and rheumatoid arthritis. The mechanism of action for hydroxychloroquine is unknown.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API).

    The OEL Fastrac monograph for Hydroxychloroquine is available for purchase for $639 USD.

  • Ulipristal Acetate


    Ulipristal acetate is a steroid indicated for prevention of unprotected pregnancy following unprotected intercourse or a known or suspected contraceptive failure and preoperative treatment of moderate to severe symptoms of uterine fibroids in adult women. Ulipristal acetate is a progesterone that prevents or delays the release of the egg from the ovary and may change the lining for the uterus to prevent pregnancy.

    Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

    The OEL Fastrac monograph for Ulipristal Acetate is available for purchase for $639 USD.

If you wish to add the feed to a feed reader, here’s the link: http://affygility.com/oel/feed.xml


mm

About Dean Calhoun

view all posts

Dean is the President and CEO of Affygility Solutions. Affygility Solutions provides environmental, health and safety software, potent compound safety, industrial hygiene, containment validation services to the pharmaceutical, biotechnology, and medical device industry. "Dean's Google+ Profile"

Affygility Solutions - provider of potent compound safety, webinars, and compliance management software